Ladostigil (Serbian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Ladostigil" in Serbian language version.

refsWebsite

Global rank Serbian rank

6nih.gov

4^th place

8^th place

4doi.org

2^nd place

4^th place

2elsevier.com

610^th place

653^rd place

1wiley.com

222^nd place

155^th place

1archive.org

6^th place

5^th place

archive.org

Weinstock M, Poltyrev T, Bejar C, Youdim MB (2002). „Effect of TV3326, a novel monoamine-oxidase cholinesterase inhibitor, in rat models of anxiety and depression”. Psychopharmacology. 160 (3): 318—24. PMID 11889501. doi:10.1007/s00213-001-0978-x.

doi.org

Weinreb O; Mandel S; Bar-Am O; et al. (2009). „Multifunctional neuroprotective derivatives of rasagiline as anti-Alzheimer's disease drugs”. Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics. 6 (1): 163—74. PMID 19110207. doi:10.1016/j.nurt.2008.10.030.
Weinreb O, Amit T, Bar-Am O, Youdim MB (2007). „Induction of neurotrophic factors GDNF and BDNF associated with the mechanism of neurorescue action of rasagiline and ladostigil: new insights and implications for therapy”. Annals of the New York Academy of Sciences. 1122: 155—68. PMID 18077571. doi:10.1196/annals.1403.011. ^{[мртва веза]}
Weinstock M, Poltyrev T, Bejar C, Youdim MB (2002). „Effect of TV3326, a novel monoamine-oxidase cholinesterase inhibitor, in rat models of anxiety and depression”. Psychopharmacology. 160 (3): 318—24. PMID 11889501. doi:10.1007/s00213-001-0978-x.
Weinstock M, Gorodetsky E, Poltyrev T, Gross A, Sagi Y, Youdim M (2003). „A novel cholinesterase and brain-selective monoamine oxidase inhibitor for the treatment of dementia comorbid with depression and Parkinson's disease”. Progress in Neuro-psychopharmacology & Biological Psychiatry. 27 (4): 555—61. PMID 12787840. doi:10.1016/S0278-5846(03)00053-8.

elsevier.com

linkinghub.elsevier.com

Weinreb O; Mandel S; Bar-Am O; et al. (2009). „Multifunctional neuroprotective derivatives of rasagiline as anti-Alzheimer's disease drugs”. Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics. 6 (1): 163—74. PMID 19110207. doi:10.1016/j.nurt.2008.10.030.
Weinstock M, Gorodetsky E, Poltyrev T, Gross A, Sagi Y, Youdim M (2003). „A novel cholinesterase and brain-selective monoamine oxidase inhibitor for the treatment of dementia comorbid with depression and Parkinson's disease”. Progress in Neuro-psychopharmacology & Biological Psychiatry. 27 (4): 555—61. PMID 12787840. doi:10.1016/S0278-5846(03)00053-8.

nih.gov

ncbi.nlm.nih.gov

Weinstock M; Bejar C; Wang RH; et al. (2000). „TV3326, a novel neuroprotective drug with cholinesterase and monoamine oxidase inhibitory activities for the treatment of Alzheimer's disease”. Journal of Neural Transmission. Supplementum (60): 157—69. PMID 11205137.
Weinreb O; Mandel S; Bar-Am O; et al. (2009). „Multifunctional neuroprotective derivatives of rasagiline as anti-Alzheimer's disease drugs”. Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics. 6 (1): 163—74. PMID 19110207. doi:10.1016/j.nurt.2008.10.030.
Weinstock M, Luques L, Bejar C, Shoham S (2006). „Ladostigil, a novel multifunctional drug for the treatment of dementia co-morbid with depression”. Journal of Neural Transmission. Supplementum (70): 443—6. PMID 17017566.
Weinreb O, Amit T, Bar-Am O, Youdim MB (2007). „Induction of neurotrophic factors GDNF and BDNF associated with the mechanism of neurorescue action of rasagiline and ladostigil: new insights and implications for therapy”. Annals of the New York Academy of Sciences. 1122: 155—68. PMID 18077571. doi:10.1196/annals.1403.011. ^{[мртва веза]}
Weinstock M, Poltyrev T, Bejar C, Youdim MB (2002). „Effect of TV3326, a novel monoamine-oxidase cholinesterase inhibitor, in rat models of anxiety and depression”. Psychopharmacology. 160 (3): 318—24. PMID 11889501. doi:10.1007/s00213-001-0978-x.
Weinstock M, Gorodetsky E, Poltyrev T, Gross A, Sagi Y, Youdim M (2003). „A novel cholinesterase and brain-selective monoamine oxidase inhibitor for the treatment of dementia comorbid with depression and Parkinson's disease”. Progress in Neuro-psychopharmacology & Biological Psychiatry. 27 (4): 555—61. PMID 12787840. doi:10.1016/S0278-5846(03)00053-8.

wiley.com

www3.interscience.wiley.com

Weinreb O, Amit T, Bar-Am O, Youdim MB (2007). „Induction of neurotrophic factors GDNF and BDNF associated with the mechanism of neurorescue action of rasagiline and ladostigil: new insights and implications for therapy”. Annals of the New York Academy of Sciences. 1122: 155—68. PMID 18077571. doi:10.1196/annals.1403.011. ^{[мртва веза]}